Evidence map›Paper›PMID 42649861›Full record

ArticleCancers2026

Defying the Unfavorable Risk: The Efficacy of LDR Brachytherapy Monotherapy in Gleason 7 Prostate Cancer: A 16-Year Single-Center Retrospective Study.

Carlos Rabaça, Domingos Roda, Guy Vieira, Bruno Pereira, Ricardo Godinho, Mário Lourenço, José Alberto Pereira, Margarida Regencio, Sofia Macedo, Rui Caetano Oliveira and 2 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos RabaçaCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.ORCID 0000-0002-3304-3803
Domingos RodaCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.ORCID 0009-0000-3542-1145
Guy VieiraCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Bruno PereiraCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Ricardo GodinhoCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Mário LourençoCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
José Alberto PereiraCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.ORCID 0000-0003-1362-1263
Margarida RegencioCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Sofia MacedoCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Rui Caetano OliveiraInstitute of Histology and Embryology, Faculty of Medicine, University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal.ORCID 0000-0002-7202-8059
Amilcar SismeiroCenter for the Treatment of Urological Diseases, R. Dom Manuel I n.° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
Anabela Mota PintoFaculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, Celas, 3000-548 Coimbra, Portugal.ORCID 0000-0002-0820-9568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

intermediate-disease-risk patientsISUP 2ISUP 3low-dose-rate brachytherapy (LDR-BT)prostate cancer

Identifiers

PMID42649861
PMCPMC13511315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.